Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Ontuxizumab [USAN:INN]
RN: 946415-62-9
UNII: 0M2XT000YC

Note

  • An antineoplastic agent that targets endosialin; in phase I clinical trials (2015).

Molecular Formula

  • C6532-H10050-N1726-O2054-S44
 

Classification Code

  • Treatment of Cancer
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Ontuxizumab [USAN:INN]

Synonyms

  • MORAb-004
  • Ontuxizumab
  • Tem1 monoclonal antibody MORAb 004
  • UNII-0M2XT000YC

Systematic Names

  • Immunoglobulin G1, anti-(human endosialin (tumor endothelial marker 1, CD248)); humanized mouse monoclonal MORAb-004 (410-phenylalanine(CH363S>F))gamma1 heavy chain (227-215')-disulfide with humanized mouse monoclonal MORAb-004 kappa light chain, dimer (233-233'':236-236'')-bisdisulfide
  • Immunoglobulin G1, anti-(human protein TEM1 (tumor endothelial marker 1)) (human-mouse monoclonal MORAb-004 heavy chain), disulfide with human-mouse monoclonal MORAb-004 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 946415-62-9

FDA UNII

  • 0M2XT000YC

System Generated Number

  • 0946415629